acut
respiratori
infect
ari
major
caus
morbid
worldwid
earliest
studi
describ
epidemiolog
infect
household
cohort
studi
largest
conduct
seattl
washington
tecumseh
michigan
provid
inform
rel
frequenc
season
symptomat
characterist
ari
shortli
mani
respiratori
virus
first
identifi
given
role
household
structur
season
incid
transmiss
respiratori
virus
primari
object
individu
longitudin
histori
infect
major
focu
inde
first
phase
tecumseh
studi
respiratori
ill
household
maintain
report
year
gradual
replac
entir
commun
could
repres
time
histor
studi
reli
cell
cultur
viru
identif
method
requir
specimen
process
quickli
consider
less
sensit
current
molecular
method
reason
tecumseh
studi
other
reli
extens
serodiagnosi
influenza
infect
use
twice
yearli
blood
specimen
possibl
time
infect
serolog
posit
limit
abil
robust
analys
transmiss
pattern
current
molecular
techniqu
becom
much
easier
identifi
broad
rang
agent
respiratori
infect
allow
document
infect
coinfect
subsequ
reinfect
collect
specimen
within
short
time
onset
symptom
still
maxim
likelihood
accur
time
identif
virus
associ
respiratori
ill
studi
transmiss
vaccin
effect
collect
regular
blood
specimen
continu
valuabl
well
viru
identif
analysi
serolog
correl
protect
household
influenza
vaccin
evalu
hive
studi
ongo
prospect
household
cohort
studi
began
hive
studi
base
origin
tecumseh
studi
respiratori
ill
sever
key
modif
ill
surveil
laboratori
method
identif
respiratori
virus
respiratori
viru
infect
gener
could
studi
primari
object
estim
effect
influenza
vaccin
use
cohort
design
comparison
studi
use
testneg
design
tnd
tnd
specimen
collect
particip
meet
respiratori
ill
case
v
c
author
acut
respiratori
infect
ari
major
caus
morbid
worldwid
earliest
studi
describ
epidemiolog
infect
household
cohort
studi
largest
conduct
seattl
washington
tecumseh
michigan
provid
inform
rel
frequenc
season
symptomat
characterist
ari
shortli
mani
respiratori
virus
first
identifi
given
role
household
structur
season
incid
transmiss
respiratori
virus
primari
object
individu
longitudin
histori
infect
major
focu
inde
first
phase
tecumseh
studi
respiratori
ill
household
maintain
report
year
gradual
replac
entir
commun
could
repres
time
histor
studi
reli
cell
cultur
viru
identif
method
requir
specimen
process
quickli
consider
less
sensit
current
molecular
method
reason
tecumseh
studi
other
reli
extens
serodiagnosi
influenza
infect
use
twice
yearli
blood
specimen
possibl
time
infect
serolog
posit
limit
abil
robust
analys
transmiss
pattern
current
molecular
techniqu
becom
much
easier
identifi
broad
rang
agent
respiratori
infect
allow
document
infect
coinfect
subsequ
reinfect
collect
specimen
within
short
time
onset
symptom
still
maxim
likelihood
accur
time
identif
virus
associ
respiratori
ill
studi
transmiss
vaccin
effect
collect
regular
blood
specimen
continu
valuabl
well
viru
identif
analysi
serolog
correl
protect
household
influenza
vaccin
evalu
hive
studi
ongo
prospect
household
cohort
studi
began
hive
studi
base
origin
tecumseh
studi
respiratori
ill
sever
key
modif
ill
surveil
laboratori
method
identif
respiratori
virus
respiratori
viru
infect
gener
could
studi
primari
object
estim
effect
influenza
vaccin
use
cohort
design
comparison
studi
use
testneg
design
tnd
tnd
specimen
collect
particip
meet
respiratori
ill
case
definit
vaccin
frequenc
compar
test
posit
influenza
test
neg
tnd
focus
individu
ill
sever
enough
seek
care
reduc
bia
due
differenti
careseek
behaviour
miss
milder
present
respiratori
viru
ill
use
prospect
cohort
design
allow
inclus
mild
ill
evalu
vaccin
effect
report
first
phase
hive
studi
conduct
includ
elig
household
live
within
mile
studi
clinic
ann
arbor
mi
least
four
individu
receiv
primari
care
univers
michigan
health
system
umh
least
two
children
year
old
elig
criteria
chang
allow
threeperson
household
recruit
rerecruit
household
summer
autumn
previous
particip
household
invit
reenrol
provid
continu
meet
elig
criteria
supplement
recruit
direct
mail
email
invit
household
sourc
popul
total
collect
data
specimen
activ
ari
surveil
individu
household
tabl
major
individu
children
year
age
white
nonhispan
femal
studi
cohort
size
rang
particip
year
household
individu
follow
longitudin
multipl
year
often
follow
activ
surveil
ari
meet
case
definit
conduct
season
octobermay
begin
octob
year
round
surveil
initi
hive
studi
particip
contact
weekli
email
phone
ascertain
new
ari
meet
studi
case
definit
particip
year
age
case
definit
consist
two
follow
symptom
cough
feverfeverish
nasal
congest
sore
throat
bodi
ach
chill
headach
particip
year
age
case
definit
consist
two
follow
symptom
cough
feverfeverish
nasal
congestionrunni
nose
troubl
breath
fussi
irrit
decreas
appetit
household
receiv
calendar
enrol
assist
record
ill
onset
date
ill
report
household
contact
studi
staff
schedul
clinic
visit
sampl
collect
ill
visit
ari
meet
case
definit
train
research
staff
collect
nasal
throat
swab
nasal
swab
particip
year
age
detect
influenza
respiratori
virus
sinc
octob
addit
selfcollect
parentcollect
specimen
also
collect
home
day
symptom
onset
begin
decemb
household
member
year
age
ask
contribut
blood
specimen
initi
enrol
visit
schedul
visit
twice
annual
thereaft
year
autumn
blood
specimen
preseason
collect
major
studi
particip
receiv
influenza
vaccin
prior
start
influenza
season
begin
novemb
spring
postseason
specimen
collect
local
influenza
circul
end
year
mayjun
annual
enrol
visit
individu
particip
queri
household
demograph
characterist
advisori
committe
immun
practic
acip
defin
highrisk
condit
detail
clinic
histori
particip
extract
umh
electron
medic
record
emr
regular
primari
care
provid
part
health
system
influenza
vaccin
inform
includ
date
lot
number
vaccin
type
dose
manufactur
confirm
use
multipl
sourc
inform
michigan
care
improv
registri
statemaintain
repositori
vaccin
record
requir
report
childhood
vaccin
michigan
request
studi
particip
providerbas
vaccin
record
obtain
directli
umh
emr
medic
record
request
individu
outsidesystem
care
provid
record
supplement
vaccin
diari
card
fill
particip
time
vaccin
histor
high
level
vaccin
uptak
hive
studi
popul
rang
tabl
respiratori
specimen
collect
ill
visit
test
realtim
revers
transcriptas
polymeras
chain
reaction
rtpcr
laboratori
confirm
influenza
use
primer
probe
center
diseas
control
prevent
influenza
subtyp
determin
influenza
specimen
lineag
determin
influenza
b
specimen
total
influenza
infect
identifi
specimen
also
test
pcr
noninfluenza
respiratori
virus
includ
respiratori
syncyti
viru
human
metapneumoviru
parainfluenza
coronaviru
rhinoviru
symptom
present
sinc
ill
onset
record
particip
complet
followup
survey
report
ill
outcom
eg
durat
symptom
care
seek
behaviour
blood
specimen
centrifug
serum
separ
store
ml
aliquot
c
process
serolog
assay
collect
sera
test
parallel
use
hemagglutinin
inhibit
hai
assay
hai
assay
use
inactiv
influenza
vaccin
subunit
materi
sanofipasteur
relev
b
vaccin
strain
antineuraminidas
antibodi
nai
measur
enzymelink
lectin
assay
ella
use
inactiv
reassort
viral
target
contain
contemporari
neuraminidas
segment
mismatch
hemagglutinin
ha
antibodi
titr
measur
blood
specimen
collect
autumn
analys
preseason
titr
come
influenza
season
well
postvaccin
titr
individu
vaccin
prior
collect
similarli
antibodi
titr
measur
blood
specimen
collect
spring
serv
postseason
titr
well
prevaccin
titr
analys
follow
studi
year
full
descript
data
collect
throughout
studi
followup
found
tabl
timelin
key
studi
activ
found
figur
origin
aim
studi
estim
influenza
vaccin
effect
annual
compar
estim
tnd
studi
conduct
outpati
clinic
season
addit
fund
expand
origin
aim
collect
blood
specimen
studi
antibodymedi
household
particip
influenzaposit
individu
influenzaposit
specimen
strain
c
immun
extend
ari
surveil
yearround
incorpor
laboratori
test
respiratori
virus
statist
analys
estim
vaccin
effect
perform
annual
adjust
hazard
ratio
ahr
estim
cox
proport
hazard
model
robust
varianc
use
sandwich
estim
account
household
cluster
adjust
model
includ
age
highrisk
health
statu
vaccin
statu
vaccin
statu
model
timevari
covari
subject
consid
vaccin
day
vaccin
receipt
vaccin
effect
calcul
x
vaccin
effect
vari
markedli
year
age
group
exampl
observ
influenza
infect
approxim
two
three
age
group
lowest
among
adult
year
howev
young
children
month
year
lowest
influenza
predomin
observ
commun
acquir
influenza
infect
confid
interv
season
observ
effect
vaccin
risk
infect
antigen
drift
influenza
point
estim
b
yamagata
near
estim
b
yamagata
appear
primarili
driven
high
effect
young
children
gener
annual
estim
influenza
consist
us
flu
network
influenza
season
found
vaccin
previou
current
year
less
protect
receiv
vaccin
current
year
first
time
recent
era
reduct
document
thu
continu
histor
debat
whether
repeat
vaccin
result
reduc
protect
origin
find
repeat
vaccin
effect
prompt
further
hypothesi
antibodi
respons
vaccin
decreas
multipl
annual
administr
vaccin
similar
antigen
makeup
order
evalu
hypothesi
began
collect
blood
specimen
decemb
season
predomin
circul
influenza
viru
rel
unvaccin
year
higher
vaccin
current
year
lower
vaccin
current
previou
year
lowest
vaccin
previou
year
addit
blood
collect
cohort
found
hai
titr
correl
observ
type
virus
lower
postvaccin
titr
found
among
vaccin
year
rel
vaccin
current
season
similar
differ
postvaccin
titr
observ
influenza
b
importantli
effect
prior
season
vaccin
serolog
suscept
infect
observ
year
season
year
influenza
predomin
found
similar
level
effect
among
vaccin
current
previou
season
compar
vaccin
current
season
consist
find
hai
nai
titr
influenza
similar
compar
vaccin
current
prior
season
vaccin
current
season
antibodi
titr
measur
twice
annual
blood
specimen
enabl
addit
evalu
relationship
vaccin
antibodymedi
protect
fact
particip
observ
time
allow
us
demonstr
highli
vaccin
cohort
prevaccin
antibodi
titr
gener
high
rise
titr
follow
vaccin
less
frequent
expect
final
measur
antibodi
titr
virus
similar
circul
local
vaccin
observ
increas
suscept
among
high
vaccinestrainspecif
antibodi
titr
low
circulatingstrainspecif
antibodi
titr
interrupt
transmiss
major
goal
influenza
prevent
strategi
could
key
control
burden
diseas
pandem
household
may
effect
place
accomplish
goal
due
high
proport
transmiss
estim
occur
set
use
standard
epidemiolog
method
estim
serial
interv
viru
type
identifi
household
individu
level
characterist
associ
secondari
infect
risk
method
remain
suscept
misclassif
transmiss
event
infect
gener
link
retrospect
base
time
onset
ill
viral
type
subtyp
despit
continu
risk
infect
commun
attempt
address
potenti
misclassif
two
way
first
possibl
use
nextgener
sequenc
differenti
two
type
transmiss
basi
genet
similar
demonstr
influenza
virus
second
adapt
individualbas
transmiss
model
account
risk
infect
commun
household
allow
chain
transmiss
hive
studi
start
identifi
virus
influenza
one
season
bacteri
agent
associ
respiratori
ill
surveil
initi
extend
much
respiratori
season
conduct
yearround
sinc
octob
thu
possibl
determin
season
respiratori
virus
addit
detect
multipl
respiratori
virus
allow
us
describ
frequenc
coinfect
differ
age
group
hive
studi
recent
receiv
continu
core
fund
recruit
exist
new
household
second
phase
cohort
commit
year
followup
yearround
surveil
ari
requir
enter
studi
blood
specimen
collect
past
limit
year
age
extend
younger
children
includ
collect
peripher
blood
mononuclear
cell
pbmc
enrol
reengag
blood
ari
surveil
figur
timelin
studi
enrol
acut
respiratori
ill
ari
surveil
blood
collect
activ
blood
collect
antibodi
studi
began
autumn
ari
surveil
carri
continu
yearround
basi
sinc
autumn
ari
surveil
limit
typic
influenza
season
prior
studi
cellmedi
immun
addit
target
recruit
strategi
focus
children
month
old
household
effort
studi
infect
immun
respons
earli
life
main
strength
hive
studi
longitudin
prospect
studi
design
intens
data
collect
activ
surveil
symptomat
ill
collect
respiratori
specimen
laboratoryconfirm
influenza
virus
allow
calcul
incid
determin
infect
time
build
previou
cohort
region
defin
ill
base
serolog
alon
use
multipl
sourc
includ
particip
medic
record
document
influenza
vaccin
statu
regular
serolog
sampl
major
strength
cohort
number
particip
prospect
follow
multipl
year
enabl
multiyear
studi
immun
respons
infect
vaccin
studi
increasingli
import
understand
individu
influenza
immun
evolv
time
ill
sampl
strategi
requir
particip
symptom
report
therefor
import
note
subclin
infect
captur
ill
sampl
would
requir
routin
swab
symptomfre
individu
howev
avail
endofseason
serolog
specimen
allow
analysi
uncaptur
influenza
viru
infect
unvaccin
individu
intens
data
collect
increas
burden
studi
particip
therefor
necessari
build
relationship
commun
ensur
enrol
longterm
particip
result
studi
resourc
intens
studi
popul
limit
term
sampl
size
generaliz
particular
sourc
popul
particip
drawn
limit
geograph
household
abl
travel
univers
michigan
studi
site
enrol
visit
blood
draw
ill
specimen
collect
hive
studi
popul
consist
suburban
resid
larg
reflect
high
educ
level
vaccin
uptak
region
one
approach
increas
sampl
size
generaliz
would
establish
multisit
cohort
present
logist
consider
might
challeng
unifi
common
protocol
inde
longitudin
cohort
respiratori
ill
use
vari
recruit
strategi
followup
method
tailor
uniqu
commun
histori
involv
commun
stretch
back
given
us
opportun
optim
cohort
longterm
success
investig
regularli
collabor
other
address
key
question
respiratori
viru
epidemiolog
immun
correl
protect
propos
futur
collabor
use
hive
studi
specimen
data
submit
studi
investig
consider
hive
studi
support
center
diseas
control
prevent
nation
institut
allergi
infecti
diseas
conflict
interest
etm
receiv
grant
support
merck
pfizer
work
unrel
report
asm
receiv
consult
fee
sanofi
seqiru
novavax
work
unrel
report
asl
receiv
consult
fee
sanofi
work
unrel
report
author
declar
conflict
interest
collect
longitudin
data
demograph
health
histori
influenza
vaccin
statu
ari
incid
collect
specimen
detect
occurr
rtpcr
influenza
respiratori
virus
serum
determin
antibodi
titr
hemagglutinin
neuraminidas
specimen
archiv
investig
interest
learn
hive
studi
well
data
specimen
avail
welcom
email
studi
investig
